What are the strange white cone structures located in fields and what do they have to do with aviation? Although they’ve been around since the 1930s and widely in use since the 1970s, Very High ...

The average one-year price target for Vor Biopharma (NasdaqGS:VOR) has been revised to $36.46 / share. This is an increase of 2,942.55% from the prior estimate of $1.20 dated September 10, 2025. The ...

Vor Bio granted Dr. Qing Zuraw stock options and RSUs as part of her employment package, effective July 17, 2025. Vor Bio, a biotechnology company focused on treating autoimmune diseases, announced ...

Vor Bio grants CEO Jean-Paul Kress an option to purchase 83.3 million shares at $0.89, vesting over four years. Vor Bio, a biotechnology company specializing in autoimmune disease treatments, ...

Vor Biopharma Inc. (VOR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, VOR's 50-day simple moving average crossed above its ...

Vor Biopharma Inc. (NYSE:VOR – Free Report) – Equities research analysts at Wedbush issued their Q1 2026 earnings estimates for Vor Biopharma in a research report issued on Thursday, May 8th. Wedbush ...

We can readily understand why investors are attracted to unprofitable companies. Indeed, Vor Biopharma (NASDAQ:VOR) stock is up 116% in the last year, providing strong gains for shareholders.